N
PTLA

Natixis’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Natixis’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-75,000
Closed -$1.35M – 920
2020
Q2 		$1.35M Buy
+75,000
New +$1.04M 0.01% 479
2018
Q1 		– Sell
-13,164
Closed -$641K – 1008
2017
Q4 		$641K Buy
+13,164
New +$666K ﹤0.01% 564

Natixis's PTLA Position: Q3 2020 in Review

Natixis sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 75,000 shares — an estimated $1.35M sold.

Natixis first reported a position in PTLA in Q4 2017 and held it in 2 quarters. The position peaked at $1.35M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Natixis reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Natixis sold 75,000 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.35M.
  • Natixis first reported a position in Portola Pharmaceuticals, Inc. in Q4 2017 and held it in 2 quarters.
  • Natixis's Portola Pharmaceuticals, Inc. position peaked at $1.35M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Natixis's 13F filing for Q3 2020, filed 12 Nov 2020.